MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 191 filers reported holding MYRIAD GENETICS INC in Q1 2020. The put-call ratio across all filers is 2.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $452,000 | -27.9% | 24,892 | 0.0% | 0.27% | -11.7% |
Q1 2022 | $627,000 | -8.7% | 24,892 | 0.0% | 0.31% | +6.9% |
Q4 2021 | $687,000 | -14.6% | 24,892 | 0.0% | 0.29% | -15.2% |
Q3 2021 | $804,000 | -10.6% | 24,892 | -15.3% | 0.34% | -17.6% |
Q2 2021 | $899,000 | +0.4% | 29,392 | 0.0% | 0.41% | -0.2% |
Q1 2021 | $895,000 | +24.3% | 29,392 | -19.2% | 0.42% | +26.1% |
Q4 2020 | $720,000 | +51.6% | 36,392 | 0.0% | 0.33% | +30.6% |
Q3 2020 | $475,000 | +200.6% | 36,392 | +162.0% | 0.25% | +196.5% |
Q2 2020 | $158,000 | -20.6% | 13,892 | 0.0% | 0.08% | -42.6% |
Q1 2020 | $199,000 | -47.4% | 13,892 | 0.0% | 0.15% | -19.1% |
Q4 2019 | $378,000 | -5.0% | 13,892 | 0.0% | 0.18% | -22.1% |
Q3 2019 | $398,000 | +3.1% | 13,892 | 0.0% | 0.24% | +7.8% |
Q2 2019 | $386,000 | -16.3% | 13,892 | 0.0% | 0.22% | +1.9% |
Q1 2019 | $461,000 | -39.0% | 13,892 | -46.6% | 0.21% | -7.4% |
Q4 2018 | $756,000 | -36.8% | 26,000 | 0.0% | 0.23% | -11.5% |
Q3 2018 | $1,196,000 | +23.0% | 26,000 | 0.0% | 0.26% | +7.9% |
Q2 2018 | $972,000 | +26.6% | 26,000 | 0.0% | 0.24% | +24.1% |
Q1 2018 | $768,000 | -14.0% | 26,000 | 0.0% | 0.20% | +1.0% |
Q4 2017 | $893,000 | -29.9% | 26,000 | -26.1% | 0.19% | -33.7% |
Q3 2017 | $1,274,000 | -18.0% | 35,200 | -41.4% | 0.29% | -17.1% |
Q2 2017 | $1,553,000 | +34.6% | 60,100 | 0.0% | 0.35% | +36.0% |
Q1 2017 | $1,154,000 | +15.2% | 60,100 | 0.0% | 0.26% | -5.1% |
Q4 2016 | $1,002,000 | +51.6% | 60,100 | +87.2% | 0.27% | +47.0% |
Q3 2016 | $661,000 | – | 32,100 | – | 0.18% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Camber Capital Management LP | 5,000,000 | $90,850,000 | 3.94% |
Altium Capital Management LP | 221,000 | $4,016,000 | 1.61% |
DISCIPLINED GROWTH INVESTORS INC /MN | 1,900,787 | $34,537,000 | 0.93% |
Zebra Capital Management LLC | 15,352 | $279,000 | 0.82% |
PFM Health Sciences, LP | 1,177,250 | $21,391,000 | 0.82% |
EARNEST PARTNERS LLC | 6,462,138 | $117,417,000 | 0.78% |
Glenview Capital Management | 1,696,791 | $30,831,000 | 0.77% |
AIMZ Investment Advisors, LLC | 42,085 | $765,000 | 0.37% |
Phocas Financial Corp. | 127,949 | $2,325,000 | 0.35% |
Redhawk Wealth Advisors, Inc. | 34,680 | $630,000 | 0.29% |